In this study, we tested the hypothesis that WD intake-induced obesity exacerbates renal I/R recovery and that TRPV1 ablation enhances renal perfusion impairment and subsequently deteriorates the recovery of renal function. Here, TRPV1 is linked to obesity disorder.